| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| XKH-001(Xinkanghe Biomedical) | XKH-001 | Phase 2 Clinical | Suzhou Kanova Biopharmaceutical Co Ltd, Beijing Kanova Biomedical Technology Co Ltd | Allergic asthma; Asthma; Inflammation | Details |